KANDIVALASA
USFDA in active mode, issues obersvations to 4 drug makers in 3 days!SMS Pharma today informed exchanges that the United States Food and Drug Administration (USFDA) conducted a cGMP inspection at Kandivalasa,...
SMS Pharma surges over 7% on USFDA nod for Andhra unitThe stock gained 7.32 per cent to settle at Rs 132 on BSE. During the day, it soared 11.78 per cent to Rs 137.50 - its 52-week high.
SMS Pharma gets USFDA approval for Andhra unitSMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and...
- Load More